0001140361-19-018079.txt : 20191007
0001140361-19-018079.hdr.sgml : 20191007
20191007192307
ACCESSION NUMBER: 0001140361-19-018079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191007
FILED AS OF DATE: 20191007
DATE AS OF CHANGE: 20191007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HENNEMAN JOHN B III
CENTRAL INDEX KEY: 0001187572
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141673
MAIL ADDRESS:
STREET 1: 311 C ENTERPRISE DRIVE
CITY: PLAINSBORO
STATE: NJ
ZIP: 08536
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
form4.xml
FORM 4
X0306
4
2019-10-07
0001781983
Aprea Therapeutics, Inc.
APRE
0001187572
HENNEMAN JOHN B III
535 BOYLSTON STREET
BOSTON
MA
02116
true
Common Stock
2019-10-07
4
P
0
5000
15
A
5000
D
Stock Option (right to Buy)
15
2019-10-07
4
A
0
18407
0
A
2029-10-02
Common Stock
18407
18407
D
Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.
/s/ Scott M. Coiante, attorney-in-fact
2019-10-07